Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Vinay Prasad, M.D., M.P.H. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
5K
Total Open
Publications
2.9K
Total
Citations
249K
Open Access
Percentage
57%
Total
Publications
5K
Total Open
Publications
2.9K
Total
Citations
249K
Breakdown
Publisher Open
16%
Both
29%
Other Platform Open
12%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
1.2K
Hybrid 15%
339
No Guarantees 33%
738
Other Platform Open
Domain 78%
1.6K
Other Internet 24%
483
Institution 15%
308
Public 5%
101
Preprint 0%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.6K |
DOI | Other Internet | 482 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 158 |
Europe PMC | Domain | 95 |
Figshare | Public | 90 |
DANS - Data Archiving and Networked Services | Institution | 26 |
Middle East Technical University - OpenMETU | Institution | 20 |
DASH - Digital Access to Scholarship at Harvard | Institution | 13 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 11 |
ZB MED - Informationszentrum Lebenswissenschaften | Institution | 8 |